NCT05075980 2026-02-13Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT StudyMayo ClinicPhase 2 Recruiting174 enrolled
NCT04895735 2026-02-02MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland CancerMayo ClinicPhase 2 Active not recruiting45 enrolled
NCT05408845 2026-01-14Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland CancersNRG OncologyPhase 2 Recruiting146 enrolled
NCT07118176 2025-08-12Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic CancersJonsson Comprehensive Cancer CenterPhase 1 Recruiting30 enrolled